Enjoy complimentary customisation on priority with our Enterprise License!
The age-related macular degeneration market size is forecast to increase by USD 5.10 billion at a CAGR of 6.54% between 2023 and 2028. The Age-related Macular Degeneration (AMD) market is experiencing significant growth due to the high prevalence of this degenerative eye condition, particularly among the aging population. According to the World Health Organization, AMD is the leading cause of vision loss in individuals over 50 years old. This trend is expected to continue as the global population ages. Strategic alliances and collaborations among market traders to develop and treat AMD are also driving market growth. However, the lack of approved therapies for dry AMD, which accounts for approximately 80-90% of AMD cases, presents a major challenge to market growth. Despite this, ongoing research and development efforts are expected to lead to new treatment options and advancements in AMD diagnosis and management.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.